These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8586915)

  • 1. [Assessing high risk group of patients for liver neoplasms by pathological findings].
    Yamada G
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1970-4. PubMed ID: 8586915
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
    Lefkowitch JH; Apfelbaum TF
    Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].
    Tarao K; Shimizu A; Okawa S; Tamai S
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1985-91. PubMed ID: 8586918
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic hepatitis C.
    Batey RG
    Aust Fam Physician; 2003 Oct; 32(10):807-11. PubMed ID: 14596076
    [No Abstract]   [Full Text] [Related]  

  • 5. Large cell dysplasia of hepatocytes, is it a premalignant condition?
    Kovács L; Elek G
    Acta Morphol Hung; 1987; 35(1-2):47-57. PubMed ID: 3124508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-cell dysplasia and hepatocellular carcinoma.
    Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G
    Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study.
    Seki S; Sakaguchi H; Kitada T; Tamori A; Takeda T; Kawada N; Habu D; Nakatani K; Nishiguchi S; Shiomi S
    Clin Cancer Res; 2000 Sep; 6(9):3469-73. PubMed ID: 10999730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of chronic hepatitis B: a retrospective study.
    Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
    Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preneoplastic lesions in chronic hepatitis C.
    Thung SN; Hytiroglou P; Fiel I; Theise N
    Princess Takamatsu Symp; 1995; 25():171-8. PubMed ID: 8875622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current approach to hepatic carcinogenesis. From cirrhosis to hepatocellular carcinoma].
    Le Bail B; Bioulac-Sage P; Tran van Nhieu J; Zafrani ES
    Ann Pathol; 1995; 15(5):332-47. PubMed ID: 8540919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients].
    Tarao K; Ohkawa S; Tamai S; Shimizu A
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):740-5. PubMed ID: 7563867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study on the correlations between HBsAg and hepatitis C virus expression as well as fibrotic staging in hepatocellular carcinoma and pericarcinomatous tissues].
    Xuan SY; Xin YN; Chen H; Shi GJ; Sun Y; Zhang J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Feb; 27(2):157-60. PubMed ID: 16750000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precancerous changes in the human liver.
    Anthony PP
    J Toxicol Environ Health; 1979; 5(2-3):301-13. PubMed ID: 224200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ; Clark V; Soldevila-Pico C; Morelli G; Cabrera R; Levy C; Machicao VI; Chaoru C; Nelson DR
    Liver Transpl; 2009 Sep; 15(9):1063-71. PubMed ID: 19718647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessing high risk group of patients for liver neoplasm by platelet count].
    Okamoto M; Omata M
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1965-9. PubMed ID: 8586914
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron, HCV, and liver cancer: hard metal setting the pace?
    Mueller S; Afdhal NH; Schuppan D
    Gastroenterology; 2006 Jun; 130(7):2229-34. PubMed ID: 16762645
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clonal analysis of regenerating nodules in hepatitis C-induced liver cirrhosis].
    Hensel F; Niederau C
    Z Gastroenterol; 1995 Oct; 33(10):628-9. PubMed ID: 7502561
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
    de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
    Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.